This text is a result of machine translation.
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Yesterday 12:13 PM
Half day main capital net inflow of power equipment, non bank finance, selling banks, etc
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
RNA Biotech Therorna Bags Over CNY 280 Mn in Series A Financing Round
Therorna, specialized in the development of cutting-edge circular RNA technology-based vaccines and therapies, will accelerate the development of a new broad-spectrum COVID-19 vaccine and other product pipelines with the fresh proceeds.
Jun 23, 2022 03:45 PM
Monitoring of main funds of star mine: Top 10 list of early trading
AI-driven pharmaceutics Company Helixon Raise CNY 500 Mn in Series A Round
As one of the key players in computational biology, Helixon received recognition from the capital market for its innovation in machine learning algorithms and data acquisition technologies which reconstruct the drug development process and improve the efficiency of new drug development.
Jun 22, 2022 06:13 PM
Pharmaceutical and biological stocks fell sharply in early trading
US Senate committee to investigate the role of cryptocurrency in cyber crime
A breakthrough in cell therapy of solid tumor by Zhifei biological joint stock company
The first bank of China fund to release its second Quarterly Report